Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma (MREO) Non-cash Items (2023 - 2025)

Mereo BioPharma (MREO) has disclosed Non-cash Items for 3 consecutive years, with $704000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Non-cash Items fell 97.05% to $704000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $704000.0, a 97.05% decrease, with the full-year FY2024 number at $2.1 million, changed N/A from a year prior.
  • Non-cash Items was $704000.0 for Q3 2025 at Mereo BioPharma, down from $1.4 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $23.9 million in Q3 2024 to a low of $978.0 in Q1 2025.
  • A 3-year average of $4.2 million and a median of $1.8 million in 2024 define the central range for Non-cash Items.
  • Biggest YoY gain for Non-cash Items was 48.7% in 2025; the steepest drop was 99.96% in 2025.
  • Mereo BioPharma's Non-cash Items stood at $6000.0 in 2022, then surged by 35283.33% to $2.1 million in 2024, then crashed by 66.84% to $704000.0 in 2025.
  • Per Business Quant, the three most recent readings for MREO's Non-cash Items are $704000.0 (Q3 2025), $1.4 million (Q2 2025), and $978.0 (Q1 2025).